Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 23, 2025 04:36 ET | Source: Research and Markets

Irritable Bowel Syndrome Treatment Global Market Report 2024-2034: Development of New Treatments, Emphasis on Personalized Medicine, and Emerging Markets Boosting Growth

Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "Irritable Bowel Syndrome Treatment Market by Type, by Product, by Distribution Channel, and by Region" report has been added to ...
September 20, 2022 06:08 ET | Source: Research and Markets

Worldwide Opioid Induced Constipation Drugs Industry to 2030 - North America Currently Leads the Market

Dublin, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The "Opioid Induced Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
September 09, 2022 05:58 ET | Source: Research and Markets

Insights on the Irritable Bowel Syndrome with Constipation Drugs Global Market to 2030 - Increasing Consumption of Spicy Food Will Spur the Market in the Asia-Pacific Region

Dublin, Sept. 09, 2022 (GLOBE NEWSWIRE) -- The "Irritable Bowel Syndrome with Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players,...
September 07, 2022 05:43 ET | Source: Research and Markets

Worldwide Chronic Idiopathic Constipation (CIC) Drugs Industry to 2030 - by Drug Type, Prescription Type and Region

Dublin, Sept. 07, 2022 (GLOBE NEWSWIRE) -- The "Chronic Idiopathic Constipation (CIC) Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
March 01, 2022 07:43 ET | Source: Research and Markets

Global Irritable Bowel Syndrome (IBS) Market Outlook Report 2022-2028: Rising Commercialization of Existing Products in Several Regions is Predicted to Accelerate Growth

Dublin, March 01, 2022 (GLOBE NEWSWIRE) -- The "Global Irritable Bowel Syndrome Market Outlook: Opportunity And Demand Analysis, Market Forecast, 2019-2028" report has been added to...
July 12, 2021 05:23 ET | Source: Research and Markets

Worldwide Irritable Bowel Syndrome Treatment Industry to 2028 - Increasing Disposable Incomes Presents Opportunities

Dublin, July 12, 2021 (GLOBE NEWSWIRE) -- The "Irritable Bowel Syndrome Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type [IBS with Diarrhea, IBS with Constipation, and...
February 26, 2021 06:18 ET | Source: Research and Markets

Worldwide Irritable Bowel Syndrome with Constipation Drugs Industry to 2028 - Rising Prevalence of Gastrointestinal Disorders Will Significantly Increase the Demand

Dublin, Feb. 26, 2021 (GLOBE NEWSWIRE) -- The "Irritable Bowel Syndrome with Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players,...
February 22, 2021 07:18 ET | Source: Research and Markets

Insights on the Opiod Induced Constipation Drugs Global Market to 2028 - by Drug Type, Prescription Type and Geography

Dublin, Feb. 22, 2021 (GLOBE NEWSWIRE) -- The "Opiod Induced Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
June 15, 2015 16:02 ET | Source: Sucampo Pharmaceuticals Inc

China Food and Drug Administration Accepts IND for Pivotal Study of AMITIZA(R) (lubiprostone)

BETHESDA, Md., June 15, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global pharmaceutical company, today announced that the China Food and Drug Administration...
December 30, 2014 17:00 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces Acceptance of New Drug Submission for AMITIZA(R) (lubiprostone) by Health Canada

BETHESDA, Md., Dec. 30, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Health Canada has accepted the...

Next Page keyboard_arrow_right